Transitioning from pediatric to adult epilepsy care

Transition to Adult Care in Epilepsy

IRCCS National Neurological Institute "C. Mondino" Foundation · NCT06778772

This study is trying to see how ready young people with epilepsy and their caregivers are to switch from pediatric to adult care, focusing on their medical and personal needs during this important change.

Quick facts

Study typeObservational
Enrollment90 (estimated)
Ages17 Years to 18 Years
SexAll
SponsorIRCCS National Neurological Institute "C. Mondino" Foundation (other)
Locations1 site (Pavia)
Trial IDNCT06778772 on ClinicalTrials.gov

What this trial studies

This observational study aims to evaluate the readiness of patients and caregivers for the transition from pediatric to adult epilepsy care. It involves comparing the Transition Readiness Assessment (TRAQ) questionnaire results at the last pediatric visit and the first adult neurology visit. The study focuses on addressing the medical, psychosocial, and educational needs of patients with epilepsy, particularly those with complex comorbidities. By implementing a collaborative transition model, the study seeks to improve multidisciplinary care during this critical period.

Who should consider this trial

Good fit: Ideal candidates are patients aged 17 or 18 years diagnosed with focal or generalized epilepsy who require ongoing follow-up.

Not a fit: Patients who are considered 'cured' from epilepsy and do not require continued follow-up will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance the quality of care and support for young adults with epilepsy as they transition to adult services.

How similar studies have performed: Other studies have shown the importance of structured transition programs, indicating potential success for this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
\*\*Inclusion Criteria:\*\*

* Patients aged 17 or 18 years.
* Diagnosed with focal or generalized epilepsy, regardless of etiology and neuropsychological, neuropsychiatric, or internal comorbidities.
* Those for whom continued epileptology follow-up is required according to standard care guidelines.

\*\*Exclusion Criteria:\*\*

* Patients undergoing EEG only for the detection of EEG abnormalities without a diagnosis of epilepsy.
* Patients for whom the last neuropsychiatric evaluation does not recommend continued epileptology follow-up (patients considered "cured" from epilepsy according to ILAE guidelines).

Where this trial is running

Pavia

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Epilepsy, epilepsy, transition

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.